Researchers retrospectively identified patients with CNS AML and evaluated several treatments and outcomes for this type of cancer at two large academic institutions.
Researchers reported on the treatment approaches and outcomes of patients with T‑cell prolymphocytic leukemia after allogeneic transplant in a multicenter, retrospective study.
The results from a multicenter, randomized, controlled phase 3 study showed that 131I-apamistamab-led allogeneic hematopoietic cell transplantation improved outcomes in older patients with active relapsed...
Researchers developed a meta-analysis to evaluate the safety and efficacy of FLT3 inhibitors on the overall survival rate and adverse events of patients with acute myeloid leukemia. Their findings were...
Researchers examined the hospitalization and mortality risk of patients with AML who were hospitalized with COVID-19. The findings of the study were presented at the Society of Hematologic Oncology 2024...
In this retrospective study, researchers assessed the turnaround time of mutational tests in patients with newly diagnosed acute myeloid leukemia (AML) and the time from diagnosis to treatment initiation....
